Sample Preparation in Genomics, Proteomics, and Epigenomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511244433

Publication Date:

November 4, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Sample Preparation in Genomics, Proteomics, and Epigenomics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Sample Preparation in Genomics, Proteomics, and Epigenomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sample Preparation in Genomics, Proteomics, and Epigenomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Sample Preparation in Genomics, Proteomics, and Epigenomics was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Sample Preparation in Genomics, Proteomics, and Epigenomics include Bio-Rad Laboratories, Inc., Danaher Corp., Merck Millipore, PerkinElmer Inc. and Qiagen GmbH, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Sample Preparation in Genomics, Proteomics, and Epigenomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sample Preparation in Genomics, Proteomics, and Epigenomics by region & country, by Type, and by Application.
The Sample Preparation in Genomics, Proteomics, and Epigenomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sample Preparation in Genomics, Proteomics, and Epigenomics.
Market Segmentation
By Company
Bio-Rad Laboratories, Inc.
Danaher Corp.
Merck Millipore
PerkinElmer Inc.
Qiagen GmbH
Segment by Type:
Instruments
Consumables
Accessories
Sample Preparation Kits
Segment by Application
Academic Institutes, and Government Institutes
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Sample Preparation in Genomics, Proteomics, and Epigenomics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Sample Preparation in Genomics, Proteomics, and Epigenomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Sample Preparation in Genomics, Proteomics, and Epigenomics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Product Introduction
1.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Forecast
1.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Trends & Drivers
1.3.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Industry Trends
1.3.2 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Drivers & Opportunity
1.3.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Challenges
1.3.4 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Players Revenue Ranking (2023)
2.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Company (2019-2024)
2.3 Key Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Sample Preparation in Genomics, Proteomics, and Epigenomics Product Offered
2.5 Key Companies Time to Begin Mass Production of Sample Preparation in Genomics, Proteomics, and Epigenomics
2.6 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Competitive Analysis
2.6.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Instruments
3.1.2 Consumables
3.1.3 Accessories
3.1.4 Sample Preparation Kits
3.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Type
3.2.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, by Type (2019-2030)
3.2.3 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Academic Institutes, and Government Institutes
4.1.2 Hospitals and Clinics
4.1.3 Pharmaceutical and Biotechnology Companies
4.1.4 Others
4.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Application
4.2.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, by Application (2019-2030)
4.2.3 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Region
5.1.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Region (2019-2024)
5.1.3 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Region (2025-2030)
5.1.4 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
5.2.2 North America Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
5.3.2 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
5.4.2 Asia Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
5.5.2 South America Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
5.6.2 Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value
6.3 United States
6.3.1 United States Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
6.3.2 United States Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
6.4.2 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
6.5.2 China Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
6.6.2 Japan Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
6.7.2 South Korea Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
6.8.2 Southeast Asia Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value, 2019-2030
6.9.2 India Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bio-Rad Laboratories, Inc.
7.1.1 Bio-Rad Laboratories, Inc. Profile
7.1.2 Bio-Rad Laboratories, Inc. Main Business
7.1.3 Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Products, Services and Solutions
7.1.4 Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (US$ Million) & (2019-2024)
7.1.5 Bio-Rad Laboratories, Inc. Recent Developments
7.2 Danaher Corp.
7.2.1 Danaher Corp. Profile
7.2.2 Danaher Corp. Main Business
7.2.3 Danaher Corp. Sample Preparation in Genomics, Proteomics, and Epigenomics Products, Services and Solutions
7.2.4 Danaher Corp. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (US$ Million) & (2019-2024)
7.2.5 Danaher Corp. Recent Developments
7.3 Merck Millipore
7.3.1 Merck Millipore Profile
7.3.2 Merck Millipore Main Business
7.3.3 Merck Millipore Sample Preparation in Genomics, Proteomics, and Epigenomics Products, Services and Solutions
7.3.4 Merck Millipore Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (US$ Million) & (2019-2024)
7.3.5 PerkinElmer Inc. Recent Developments
7.4 PerkinElmer Inc.
7.4.1 PerkinElmer Inc. Profile
7.4.2 PerkinElmer Inc. Main Business
7.4.3 PerkinElmer Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Products, Services and Solutions
7.4.4 PerkinElmer Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (US$ Million) & (2019-2024)
7.4.5 PerkinElmer Inc. Recent Developments
7.5 Qiagen GmbH
7.5.1 Qiagen GmbH Profile
7.5.2 Qiagen GmbH Main Business
7.5.3 Qiagen GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Products, Services and Solutions
7.5.4 Qiagen GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (US$ Million) & (2019-2024)
7.5.5 Qiagen GmbH Recent Developments
8 Industry Chain Analysis
8.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Industrial Chain
8.2 Sample Preparation in Genomics, Proteomics, and Epigenomics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Sales Model
8.5.2 Sales Channel
8.5.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Bio-Rad Laboratories, Inc.
Danaher Corp.
Merck Millipore
PerkinElmer Inc.
Qiagen GmbH

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂